Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Clinical trial NCT07271186 · RECRUITING
Trial details
- NCT number
- NCT07271186
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-09
- Primary completion
- 2027-09-24
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.